Blood Journal
Leading the way in experimental and clinical research in hematology

Point mutations in the beta-subunit of cytochrome b558 leading to X- linked chronic granulomatous disease

  1. BG Bolscher,
  2. M de Boer,
  3. A de Klein,
  4. RS Weening, and
  5. D Roos
  1. Central Laboratory of the Netherlands Red Cross Blood Transfusion Service, Amsterdam.


The NADPH:O2 oxidoreductase of phagocytic leukocytes is an important enzyme for the bactericidal activity of these cells. Cytochrome b558 is a membrane component of this enzyme. In X-linked chronic granulomatous disease (Xb- CGD) the phagocytes are defective in the beta-subunit (gp91-phox) of this cytochrome. We have studied the genetic defect in a group of six X-linked CGD patients characterized by complete or partial loss of cytochrome b558 with the use of the polymerase chain reaction. All patients had a different single point mutation in the gp91-phox gene, indicating that the genetic defect in Xb- CGD is very heterogeneous. In one patient the mutation leads to a premature termination codon. In the other five cases these mutations predict incorporation of a different amino acid. The mutations were with one exception found in the N-terminal half of the protein, suggesting that this part of cytochrome b558 is important for the binding of the heme or for formation of a stable complex with p22-phox. Two histidyl residues were found that might be ligands of the heme iron.